Miriam Rubinchik-Stern

Miriam Rubinchik-Stern

Auto-generated profile, based on publicly available information

Miriam Rubinchik-Stern

Department of Obstetrics & Gynecology, E. Wolfson Medical Center affiliated with Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2018 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
NTNino Tetro
Nino Tetro
SMSonia Moushaev
Sonia Moushaev
MRMiriam Rubinchik-Stern
Miriam Rubinchik-Stern
SESara Eyal
Sara Eyal

1 January 2012 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
MRMiriam Rubinchik-Stern
Miriam Rubinchik-Stern
SESara Eyal
Sara Eyal
Pregnant women (and their fetuses) are treated with a significant number of prescription and non-prescription medications. Interactions among those drugs may affect their efficacy and toxicity in both mother and fetus. Whereas interactions that result in altered drug concentrations in maternal plasma are detectable, those involving modulation of placental transfer mechanisms are rarely reflected by altered drug concentrations in maternal plasma. Therefore, they are often overlooked. Placental-mediated interactions are possible because the placenta is not only a passive diffusional barrier, but also expresses a variety of influx and efflux transporters and drug-metabolizing enzymes. Current data on placental-mediated drug interactions are limited. In rodents, pharmacological or genetic manipulations of placental transporters significantly affect fetal drug exposure. In contrast, studies in human placentae suggest that the magnitude of such interactions is modest in most cases. Nevertheless, under certain circumstances, such interactions may be of clinical significance. This review describes currently known mechanisms of placental-mediated drug interactions and the potential implications of such interactions in humans. Better understanding of those mechanisms is important for minimizing fetal toxicity from drugs while improving their efficacy when directed to treat the fetus.

29 May 2015 in Epilepsia
Verified
Journal Article
Closed access
PDF file
MRMiriam Rubinchik‐Stern
Miriam Rubinchik‐Stern
MSMiri Shmuel
Miri Shmuel
SESara Eyal
Sara Eyal

17 April 2018 in Epilepsia
Verified
Journal Article
Closed access
PDF file
MRMiriam Rubinchik‐Stern
Miriam Rubinchik‐Stern
MSMiriam Shmuel
Miriam Shmuel
JBJacob Bar
Jacob Bar
Michal KovoMichal Kovo
Michal Kovo
SESara Eyal
Sara Eyal

1 July 2016 in Reproductive Toxicology
Verified
Journal Article
Closed access
MRMiriam Rubinchik-Stern
Miriam Rubinchik-Stern
MSMiriam Shmuel
Miriam Shmuel
JBJacob Bar
Jacob Bar
SESara Eyal
Sara Eyal
Michal KovoMichal Kovo
Michal Kovo

1 October 2018 in Thrombosis Research
Verified
Journal Article
Closed access
Michal KovoMichal Kovo
Michal Kovo
MRMiriam Rubinchik-Stern
Miriam Rubinchik-Stern
HMHadas Miremberg
Hadas Miremberg
OLOded Luria
Oded Luria
IBInna Bliecher
Inna Bliecher
JBJacob Bar
Jacob Bar